Compare BSX & BUD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BSX | BUD |
|---|---|---|
| Founded | 1979 | 1366 |
| Country | United States | Belgium |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 137.8B | 138.6B |
| IPO Year | 1992 | N/A |
| Metric | BSX | BUD |
|---|---|---|
| Price | $76.27 | $75.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 20 | 1 |
| Target Price | ★ $109.30 | $88.00 |
| AVG Volume (30 Days) | ★ 18.2M | 2.1M |
| Earning Date | 02-04-2026 | 02-12-2026 |
| Dividend Yield | N/A | ★ 1.29% |
| EPS Growth | ★ 55.20 | N/A |
| EPS | 1.94 | ★ 3.00 |
| Revenue | $20,074,000,000.00 | ★ $58,605,000,000.00 |
| Revenue This Year | $12.53 | $0.67 |
| Revenue Next Year | $10.88 | $5.43 |
| P/E Ratio | $40.02 | ★ $25.01 |
| Revenue Growth | ★ 19.87 | N/A |
| 52 Week Low | $74.86 | $48.59 |
| 52 Week High | $109.50 | $75.73 |
| Indicator | BSX | BUD |
|---|---|---|
| Relative Strength Index (RSI) | 26.16 | 84.97 |
| Support Level | $74.86 | $74.32 |
| Resistance Level | $94.21 | $75.73 |
| Average True Range (ATR) | 2.61 | 0.97 |
| MACD | -1.67 | 0.45 |
| Stochastic Oscillator | 14.08 | 98.44 |
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
Anheuser-Busch InBev is the largest brewer in the world and one of the world's top five consumer product companies, as measured by EBITDA. The company's portfolio contains six of the top 10 beer brands by volume, according to Euromonitor, and we estimate it distributes 23 brands with retail sales over $1 billion. AB InBev was created by the 2008 merger of Belgium-based InBev and US-based Anheuser-Busch. The firm holds a 62% economic interest in Ambev, an 87% stake in Budweiser APAC, and in 2016 it acquired SABMiller.